GTR 120237900
Tenders Are Invited For Administrative Healthcare Services – Open Procedure For The Assignment Of Services To A Contract Research Organization (Cro) For The Management Of The Multi-Center Randomized Clinical Trial: “Comboseq - Sequence Strategy Of Immuneoncology (Io-Io) Vs Io-Tyrosine Kinase Inhibitors (Tki) Followed By Tki In Metastatic Renal Cell Carcinoma (Mrcc): A Randomized Phase 3 Study Meeturo And Ficog Trial”, Via Sintel Platform
ICB — International Competitive Bid
Closes Nov 24, 2026
— 4 days left
Southern Europe
Tender Information
GTR Reference
120237900
Tendering Authority
Subscribe to view
Tender No
766672-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Administrative Healthcare Services – Open Procedure For The Assignment Of Services To A Contract Research Organization (Cro) For The Management Of The Multi-Center Randomized Clinical Trial: “Comboseq - Sequence Strategy Of Immuneoncology (Io-Io) Vs Io-Tyrosine Kinase Inhibitors (Tki) Followed By Tki In Metastatic Renal Cell Carcinoma (Mrcc): A Randomized Phase 3 Study Meeturo And Ficog Trial”, Via Sintel Platform
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Southern Europe
Political Region
European Union,G20
Last Date of Bid Submission
24-11-2026
4 days left
Work Detail
Administrative Healthcare Services – Open Procedure For The Assignment Of Services To A Contract Research Organization (Cro) For The Management Of The Multi-Center Randomized Clinical Trial: “Comboseq - Sequence Strategy Of Immuneoncology (Io-Io) Vs Io-Tyrosine Kinase Inhibitors (Tki) Followed By Tki In Metastatic Renal Cell Carcinoma (Mrcc): A Randomized Phase 3 Study Meeturo And Ficog Trial”, Via Sintel Platform. Open Procedure For The Assignment Of Services To A Contract Research Organization (Cro) For The Management Of The Multi-Center Randomized Clinical Trial “Comboseq - Sequence Strategy Of Immuneoncology (Io-Io) Vs Io-Tyrosine Kinase Inhibitors (Tki) Followed By Tki In Metastatic Renal Cell Carcinoma (Mrcc) A Randomized Phase 3 Study Meeturo And Ficog Trial”, Via Sintel Platform
Key Value
Tender Value
2,024,000 - EUR
Tender Documents
Global Tender Document
659b95fb-22a3-4c79-b9a1-cce2bf0f417f.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.